BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8759187)

  • 1. Non-islet cell tumour-associated hypoglycaemia: 111In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids.
    Perros P; Simpson J; Innes JA; Teale JD; McKnight JA
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):727-31. PubMed ID: 8759187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH).
    Teale JD; Marks V
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):491-8. PubMed ID: 9876347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The palliative management of non-islet cell tumour hypoglycaemia with glucocorticoids and somatostatin analogues in an unresectable hepatocellular carcinoma.
    North AS; Thakkar RG; James RA; Hammond JS
    Ann R Coll Surg Engl; 2022 Jun; 104(6):e180-e182. PubMed ID: 35133207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non islet cell tumor hypoglycaemia in a metastatic Leydig cell tumor.
    Mukherjee S; Diver M; Weston PJ
    Acta Oncol; 2005; 44(7):761-3. PubMed ID: 16227169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related effects of growth hormone on IGF-I and IGF-binding protein-3 levels in non-islet cell tumour hypoglycaemia.
    Drake WM; Miraki F; Siddiqi A; Yateman M; Barnes NC; Camacho-Hübner C; Monson JP
    Eur J Endocrinol; 1998 Nov; 139(5):532-6. PubMed ID: 9849819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia.
    Teale JD; Wark G
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):457-60. PubMed ID: 15049960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.
    Alberts AS; Falkson G
    S Afr Med J; 1988 Jul; 74(2):75-6. PubMed ID: 2899913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.
    Vezzosi D; Bennet A; Rochaix P; Courbon F; Selves J; Pradere B; Buscail L; Susini C; Caron P
    Eur J Endocrinol; 2005 May; 152(5):757-67. PubMed ID: 15879362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases.
    de Groot JW; Rikhof B; van Doorn J; Bilo HJ; Alleman MA; Honkoop AH; van der Graaf WT
    Endocr Relat Cancer; 2007 Dec; 14(4):979-93. PubMed ID: 18045950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Column chromatographic characterization of complex formation of pro-IGF-II isoforms with acid labile subunit and IGF-binding proteins associated with non-islet cell tumour induced hypoglycaemia.
    van Veggel KM; Huits RM; Donker GH; Lentjes EG; van Doorn J
    Growth Horm IGF Res; 2014 Dec; 24(6):233-8. PubMed ID: 25174810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid therapy ameliorated hypoglycemia in insulin-like growth factor-II-producing solitary fibrous tumor.
    Tsuro K; Kojima H; Okamoto S; Yoshiji H; Fujimoto M; Uemura M; Yoshikawa M; Nakamura T; Kou S; Nakajima Y; Fukui H
    Intern Med; 2006; 45(8):525-9. PubMed ID: 16702745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of hypoglycaemia in a patient with pancreatic microadenomatosis by a long-acting somatostatin analogue SMS 201-995.
    Kung AW; Ma JT; Wang C; Fu KH; Lam KS; Yeung RT; Boey J
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):469-73. PubMed ID: 2893673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic usefulness of radiolabeled pentetreotide scintigraphy and therapeutic efficiency of octreotide in a case of insulinoma.
    Cuvelier C; Pochet JM; Col V; Jonard P; Pauwels S; Cuvelier A
    Acta Clin Belg; 1994; 49(6):296-301. PubMed ID: 7871936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin.
    Hunter SJ; Daughaday WH; Callender ME; McKnight JA; McIlrath EM; Teale JD; Atkinson AB
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):397-401; discussion 402. PubMed ID: 7525121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Big insulin-like growth factor 2-producing multiple solitary fibrous tumors treated with debulking surgery: A case report.
    Keidai Y; Murakami T; Yamamura N; Tsunoda S; Ikeda A; Hida K; Nagao M; Yamada Y; Fukui A; Ogura M; Fukuda I; Nakamoto Y; Obama K; Inagaki N
    Front Endocrinol (Lausanne); 2023; 14():1071899. PubMed ID: 36742395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor imaging in somatotroph and non-functioning pituitary adenomas: correlation with hormonal and visual responses to octreotide.
    Broson-Chazot F; Houzard C; Ajzenberg C; Nocaudie M; Duet M; Mundler O; Marchandise X; Epelbaum J; Gomez De Alzaga M; Schäfer J; Meyerhof W; Sassolas G; Warnet A
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):589-98. PubMed ID: 9425399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.
    Bourcigaux N; Arnault-Ouary G; Christol R; Périn L; Charbonnel B; Le Bouc Y
    Clin Ther; 2005 Feb; 27(2):246-51. PubMed ID: 15811488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.